Lini Imaji Kreasi Ekosistem Tbk. vs Merck Tbk. — how do they compare? Lini Imaji Kreasi Ekosistem Tbk. trades at Rp336 (market cap 2.19T, 56.39M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Lini Imaji Kreasi Ekosistem Tbk. is the larger of the two by market cap, and Lini Imaji Kreasi Ekosistem Tbk. is more actively traded (56.39M versus 29.1K). Which is the better fit depends on your goals.
| FUTR | MERK | |
|---|---|---|
Market Cap | 2.19T | 1.75T |
Volume | 56.39M | 29.1K |
Lot | 563.87K | 291 |
Turnover | 18.95B | 113.37M |
Average Price | 336.07 | 3,895.98 |
Value | 18.95B | 113.37M |
Indicative Equilibrium Price | 336 | 3,890 |
Indicative Equilibrium Volume | 6.06K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.
Read more on FUTR →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →